Switch to:
More From Other Websites
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jul 21 2014
Navidea Biopharmaceuticals Announces 2014 Annual Meeting Results Jul 17 2014
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 16 2014
Navidea Joins Essex Woodland’s Rheumco to Develop Radiopharmaceuticals for Detection and Treatment... Jul 16 2014
Navidea Joins Essex Woodland’s Rheumco to Develop Radiopharmaceuticals for Detection and Treatment... Jul 16 2014
Navidea to Webcast Investor Briefing on Sentinel Lymph Node Biopsy in Head & Neck Cancers July 8,... Jul 02 2014
Navidea to Webcast Investor Briefing on Sentinel Lymph Node Biopsy in Head & Neck Cancers July 8,... Jul 02 2014
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events,... Jun 16 2014
Navidea confirms FDA approval of expanded use for Lymphoseek Jun 13 2014
U.S. FDA Approves Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept)... Jun 13 2014
Biotech Stock Mailbag: Vanda, Navidea, Provectus Jun 13 2014
Navidea (NAVB) Worth Watching: Stock Up 7.3% Jun 12 2014
Navidea announces results from post-hoc analysis from Lymphoseek injection trial Jun 11 2014
Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates... Jun 11 2014
Navidea Biopharmaceuticals Announces Positive Lymphoseek® (technetium Tc 99m tilmanocept) Injection... Jun 10 2014
Navidea Announces Data Demonstrating Potential of Manocept™ Platform to Diagnose Rheumatoid... Jun 10 2014
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 02 2014
Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference May 29 2014
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® and Manocept™... May 20 2014
Navidea price target lowered to $3 from $5 at JMP Securities May 19 2014
UPDATE: JMP Securities Reiterates On Navidea Biopharmaceuticals On Pipeline Restructuring May 19 2014
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German... Mar 26 2014
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for... Mar 19 2014
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence and Survival... Mar 14 2014
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC Mar 06 2014
Navidea Announces Fourth Quarter and Full Year 2013 Results Mar 06 2014
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek®... Mar 05 2014
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on... Mar 03 2014
Navidea Biopharmaceuticals Adds New Member to Board of Directors Feb 19 2014
Navidea Announces Priority Review for the sNDA to Expand Lymphoseek® Labeling for Sentinel Lymph... Feb 18 2014
Navidea Biopharmaceuticals Announces the Presentation of Manocept™ Data at Keystone Symposia for... Feb 13 2014
Navidea Biopharmaceuticals Announces Positive Initial Results in Single-Center Cohort from Phase 2b... Feb 06 2014
Navidea Biopharmaceuticals to Present at the 16th Annual BIO CEO and Investor Conference Feb 04 2014
Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase™ Conference Jan 07 2014
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts Jan 07 2014
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts Jan 07 2014
European Medicines Agency (EMA) Continues Marketing Authorization Application (MAA) Review for... Dec 19 2013
Navidea Biopharmaceuticals Submits Supplemental New Drug Application (sNDA) for Lymphoseek® for... Dec 17 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek® for Sentinel Lymph... Dec 10 2013


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide